Public-registry site landscape for NCT06054477, a Head and Neck Cancer study sponsored by Alentis Therapeutics AG. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06054477 (registry record) |
| Sponsor | Alentis Therapeutics AG |
| Condition(s) | Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 22 |
| Site countries | United States, Canada, France, Hong Kong, Italy, Singapore, Spain, Switzerland |
Eichor generates a preliminary site-risk snapshot for NCT06054477 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →